1,408
Participants
Start Date
October 31, 2012
Primary Completion Date
June 30, 2016
Cat-PAD
1 dose every 4 weeks
Placebo
1 dose every 4 weeks
Rolling Hills Estates
Colorado Springs
Denver
Wheat Ridge
Eagle
Meridian
Chicago
Evanston
Forrest
Normal
Iowa City
Overland Park
Bangor
Brockton
Ypsilanti
Minneapolis
Kansas City
St Louis
Bozeman
Missoula
Bellevue
Fremont
Omaha
Ocean Township
Albuquerque
Corning
Newburgh
Fargo
Minot
Canton
Cincinnati
Middleburg Heights
Sylvania
Toledo
Tulsa
Lake Oswego
Medford
Portland
Blue Bell
Pittsburgh
Germantown
Nashville
Dallas
San Antonio
Draper
Glen Allen
South Burlington
Warrenton
Spokane
Greenfield
Madison
Milwaukee
Brussels
Ghent
Leuven
Burlington
Corruna
Hamilton
Kanata
London
Newmarket
Niagara Falls
Oshawa
Ottawa
Toronto
Montreal
Pointe-Claire
Québec
Trois-Rivières
Brnho
Čáslav
České Budějovice
Jablonec nad Nisou
Kutná Hora
Prague
Rychnov nad Kněžnou
Berlin
Bonn
Bramsche
Cologne
Hamburg
Heidelberg
Mönchengladbach
München
Münster
Neuss
Osnabrück
Wesel
Wiesbaden
Wuppertal
Budapest
Csorna
Pécs
Tatabánya
Bydgoszcz
Gdansk
Katowice
Krakow
Lodz
Lublin
Poznan
Rzeszów
Tarnów
Warsaw
Wroclaw
Zabrze
Zawadzkie
Barnaul
Moscow
Novosibirsk
Omsk
Saint Petersburg
Stavropol
Tomsk
Yekaterinburg
Bardejov
Martin
Poprad
Collaborators (2)
inVentiv Health Clinical
OTHER
Pharm-Olam International
INDUSTRY
Circassia Limited
INDUSTRY